Follow
Farheen Sultana mohammed
Farheen Sultana mohammed
Associate staff Scientist, Wistar Institute
Verified email at wistar.org
Title
Cited by
Cited by
Year
Quinazolinone linked pyrrolo [2, 1-c][1, 4] benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents
A Kamal, EV Bharathi, MJ Ramaiah, D Dastagiri, JS Reddy, A Viswanath, ...
Bioorganic & medicinal chemistry 18 (2), 526-542, 2010
1072010
Design, synthesis and biological evaluation of 3, 5-diaryl-isoxazoline/isoxazole-pyrrolobenzodiazepine conjugates as potential anticancer agents
A Kamal, JS Reddy, MJ Ramaiah, D Dastagiri, EV Bharathi, MA Azhar, ...
European journal of medicinal chemistry 45 (9), 3924-3937, 2010
942010
3‐Substituted 2‐Phenylimidazo [2, 1‐b] benzothiazoles: Synthesis, Anticancer Activity, and Inhibition of Tubulin Polymerization
A Kamal, F Sultana, MJ Ramaiah, YVV Srikanth, A Viswanath, C Kishor, ...
ChemMedChem 7 (2), 292-300, 2012
422012
2-Anilinonicotinyl linked 2-aminobenzothiazoles and [1, 2, 4] triazolo [1, 5-b][1, 2, 4] benzothiadiazine conjugates as potential mitochondrial apoptotic inducers
A Kamal, YVV Srikanth, MNA Khan, M Ashraf, MK Reddy, F Sultana, ...
Bioorganic & medicinal chemistry 19 (23), 7136-7150, 2011
372011
Recent advances on structural modifications of benzothiazoles and their conjugate systems as potential chemotherapeutics
K Ahmed, S Yellamelli Valli Venkata, NAK Mohammed, F Sultana, ...
Expert Opinion on Investigational Drugs 21 (5), 619-635, 2012
362012
Anti-tubercular agents. Part 7: A new class of diarylpyrrole–oxazolidinone conjugates as antimycobacterial agents
A Kamal, P Swapna, RV Shetti, AB Shaik, MPN Rao, F Sultana, IA Khan, ...
European journal of medicinal chemistry 64, 239-251, 2013
272013
Synthesis of tetrazole–isoxazoline hybrids as a new class of tubulin polymerization inhibitors
A Kamal, A Viswanath, MJ Ramaiah, J Murty, F Sultana, G Ramakrishna, ...
MedChemComm 3 (11), 1386-1392, 2012
242012
Synthesis, anticancer activity and apoptosis inducing ability of anthranilamide-PBD conjugates
A Kamal, EV Bharathi, MJ Ramaiah, JS Reddy, D Dastagiri, A Viswanath, ...
Bioorganic & medicinal chemistry letters 20 (11), 3310-3313, 2010
212010
3-Diarylethyne quinazolinones: a new class of senescence inducers
A Kamal, F Sultana, MJ Ramaiah, YVV Srikanth, A Viswanath, ...
MedChemComm 4 (3), 575-581, 2013
92013
Synthesis and biological evaluation of diaryl ether linked DC-81 conjugates as potential antitumor agents
A Kamal, A Viswanath, M Janaki Ramaiah, J NSRC Murty, F Sultana, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013
62013
Eur. J. Med. Chem.
A Kamal, JS Reddy, MJ Ramaiah, D Dastagiri, EV Bharathi, MA Azhar, ...
52011
Styryl quinazolinones and its ethynyl derivatives induce myeloid differentiation
S Radhakrishnan, R Syed, H Takei, IS Kobayashi, E Nakamura, F Sultana, ...
Bioorganic & medicinal chemistry letters 29 (16), 2286-2289, 2019
22019
3-arylethynyl substituted quinazolinone compounds
A Kamal, F Sultana, EV Bharathi, YVV Srikanth, A Viswanath, P Swapna
US Patent 8,680,272, 2014
12014
Post-PCI Clinical Outcomes of Reduced Dose Prasugrel in Comparison to Clopidogrel
MF Khan, F Sultana, O Mushtaq, M Sultana, GR Reddy, A Golla, ...
Asian Journal of Cardiology Research 7 (3), 7-17, 2022
2022
3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation thereof useful as potential anticancer agents
A Kamal, R Nayak, F Sultana
US Patent 9,783,537, 2017
2017
SYNTHESES, ACTIVITIES AND METHODS OF USE OF DIHYDRONICOTINAMIDE RIBOSIDE DERIVATIVES
Anthony Sauve, Farheen Sultana Mohammed, Yue Yang
US Patent WO 2017/011788 A l, 2017
2017
EFFICIENT SYNTHESIS OF NICOTINAMIDE MONONUCLEOTIDE
A Sauve, F Mohammed
US Patent WO2016/160524A1, 2016
2016
Synthesis and Anticancer activity of New Pyrrolobenzodiazepine, Quinazolinone, Imidazothiazole and Chalcone Deriavatives
F Sultana
2013
trans‐4‐Hydroxy‐l‐proline
A Kamal, F Sultana
Encyclopedia of Reagents for Organic Synthesis, 2001
2001
The system can't perform the operation now. Try again later.
Articles 1–19